These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33652898)

  • 41. United healthcare, five oncology practices try bundled payments.
    Goozner M
    J Natl Cancer Inst; 2011 Jan; 103(1):8-10. PubMed ID: 21169535
    [No Abstract]   [Full Text] [Related]  

  • 42. Value-based pricing: Toward achieving a balance between individual and population gains in health benefits.
    Parmar A; Jiao T; Saluja R; Chan KKW
    Cancer Med; 2020 Jan; 9(1):94-103. PubMed ID: 31711274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research.
    Takahari D; Shinozaki E; Wakatsuki T; Ooki A; Ozaka M; Suzuki T; Nakayama I; Osumi H; Kamiimabeppu D; Sato T; Ogura M; Suenaga M; Chin K; Yamaguchi K
    Int J Clin Oncol; 2021 Feb; 26(2):335-344. PubMed ID: 33085057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted immunotherapies overtaking emerging oncology market value based growth.
    Jakovljevic MB
    J BUON; 2015; 20(1):350-1. PubMed ID: 25778340
    [No Abstract]   [Full Text] [Related]  

  • 45. Engaging the Canadian public on reimbursement decision-making for drugs for rare diseases: a national online survey.
    Polisena J; Burgess M; Mitton C; Lynd LD
    BMC Health Serv Res; 2017 May; 17(1):372. PubMed ID: 28549479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How do cost-effectiveness analyses inform reimbursement decisions for oncology medicines in Canada? The example of sunitinib for first-line treatment of metastatic renal cell carcinoma.
    Chabot I; Rocchi A
    Value Health; 2010; 13(6):837-45. PubMed ID: 20561332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seeing beyond COVID-19: understanding the impact of the pandemic on oncology, and the importance of preparedness.
    Carrieri D; Peccatori FA
    Hist Philos Life Sci; 2020 Nov; 42(4):57. PubMed ID: 33210170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost effectiveness of EML4-ALK fusion testing and first-line crizotinib treatment for patients with advanced ALK-positive non-small-cell lung cancer.
    Djalalov S; Beca J; Hoch JS; Krahn M; Tsao MS; Cutz JC; Leighl NB
    J Clin Oncol; 2014 Apr; 32(10):1012-9. PubMed ID: 24567430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hidradenitis suppurativa patient perspectives during the COVID-19 pandemic.
    Price KN; Collier EK; Grogan TR; Hsiao JL; Shi VY
    Dermatol Online J; 2021 Feb; 27(2):. PubMed ID: 33818992
    [No Abstract]   [Full Text] [Related]  

  • 50. Understanding the reasons for provincial discordance in cancer drug funding-a survey of policymakers.
    Srikanthan A; Penner N; Chan KKW; Sabharwal M; Grill A
    Curr Oncol; 2018 Aug; 25(4):257-261. PubMed ID: 30111966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hospital organization and thoracic oncological patient management during the coronavirus disease-2019 outbreak: a brief report from a nationwide survey of the Italian Society of Thoracic Surgery.
    Viggiano D; Lococo F; Dell'Amore A; Crisci R; Torre M; Rea F; Muriana G;
    Interact Cardiovasc Thorac Surg; 2020 Dec; 31(6):895-899. PubMed ID: 33089301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Managed care & medical oncology: the focus is on value.
    Danielson E; Demartino J; Mullen JA
    J Natl Compr Canc Netw; 2010 Sep; 8 Suppl 7():S28-37. PubMed ID: 20947721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Forecasting Ontario Oncology Drug Expenditures: A Hybrid Approach to Improving Accuracy.
    Murray PM; Shalaby YA; Ieraci L; Borg E; Sniekers D; Esensoy AV; Arias J
    Appl Health Econ Health Policy; 2020 Feb; 18(1):127-137. PubMed ID: 31724104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Value assessment in oncology drugs: funding of drugs for metastatic breast cancer in Canada.
    Lemieux J; Audet S
    Curr Oncol; 2018 Jun; 25(Suppl 1):S161-S170. PubMed ID: 29910659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of comparative effectiveness research in cancer funding decisions in Ontario, Canada.
    Hoch JS; Hodgson DC; Earle CC
    J Clin Oncol; 2012 Dec; 30(34):4262-6. PubMed ID: 23071242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Knowledge, attitudes and practices related to the COVID-19 outbreak among Romanian adults with cancer: a cross-sectional national survey.
    Gheorghe AS; Negru ŞM; Nițipir C; Mazilu L; Marinca M; Gafton B; Ciuleanu TE; Schenker M; Dragomir RD; Gheorghe AD; Stovicek PO; Bandi-Vasilica M; Boț AC; Mihăilă RI; Zob DL; Kajanto AL; Stănculeanu DL
    ESMO Open; 2021 Feb; 6(1):100027. PubMed ID: 33399089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of COVID 19 on the provision of surgical services in Ontario, Canada: population-based analysis.
    Gomez D; Dossa F; Sue-Chue-Lam C; Wilton AS; de Mestral C; Urbach D; Baxter N
    Br J Surg; 2021 Jan; 108(1):e15-e17. PubMed ID: 33640924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using Data From Ontario's Episode-Based Funding Model to Assess Quality of Chemotherapy.
    Kaizer L; Simanovski V; Lalonde C; Tariq H; Blais I; Evans WK
    J Oncol Pract; 2016 Oct; 12(10):e870-e877. PubMed ID: 27858565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolution of a Systematic Approach to Smoking Cessation in Ontario's Regional Cancer Centres.
    Cameron E; Lee V; Rana S; Haque M; Schwartz N; Khan S; Truscott R; Rabeneck L
    Curr Oncol; 2022 Jun; 29(7):4604-4611. PubMed ID: 35877225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. School Attendance Among Pediatric Oncology Patients During the COVID-19 Pandemic in Ontario, Canada.
    Carson JJK; Coo H; Al Nuaimi M; Punnett A; Leifso K; Wheaton L
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):e164-e168. PubMed ID: 38277622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.